Vertex Pharmaceuticals (BER:VX1) Price Target Increased by 10.91% to 341.78

The average one-year price target for Vertex Pharmaceuticals (BER:VX1) has been revised to 341.78 / share. This is an increase of 10.91% from the prior estimate of 308.16 dated April 6, 2023. The price target is an average of many targets provided by analysts.